JP2021531312A5 - - Google Patents
Info
- Publication number
- JP2021531312A5 JP2021531312A5 JP2021504238A JP2021504238A JP2021531312A5 JP 2021531312 A5 JP2021531312 A5 JP 2021531312A5 JP 2021504238 A JP2021504238 A JP 2021504238A JP 2021504238 A JP2021504238 A JP 2021504238A JP 2021531312 A5 JP2021531312 A5 JP 2021531312A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- conjugate
- influenza virus
- agent
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023212681A JP2024029005A (ja) | 2018-07-26 | 2023-12-18 | 抗インフルエンザ化学療法および免疫療法のための低分子リガンド標的指向性薬物結合体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862703534P | 2018-07-26 | 2018-07-26 | |
| US62/703,534 | 2018-07-26 | ||
| US201962846549P | 2019-05-10 | 2019-05-10 | |
| US62/846,549 | 2019-05-10 | ||
| PCT/US2019/042715 WO2020023323A1 (en) | 2018-07-26 | 2019-07-20 | Small molecule ligand-targeted drug conjugates for anti-influenza chemotherapy and immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212681A Division JP2024029005A (ja) | 2018-07-26 | 2023-12-18 | 抗インフルエンザ化学療法および免疫療法のための低分子リガンド標的指向性薬物結合体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021531312A JP2021531312A (ja) | 2021-11-18 |
| JP2021531312A5 true JP2021531312A5 (https=) | 2022-07-26 |
Family
ID=69180703
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504238A Pending JP2021531312A (ja) | 2018-07-26 | 2019-07-20 | 抗インフルエンザ化学療法および免疫療法のための低分子リガンド標的指向性薬物結合体 |
| JP2023212681A Pending JP2024029005A (ja) | 2018-07-26 | 2023-12-18 | 抗インフルエンザ化学療法および免疫療法のための低分子リガンド標的指向性薬物結合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212681A Pending JP2024029005A (ja) | 2018-07-26 | 2023-12-18 | 抗インフルエンザ化学療法および免疫療法のための低分子リガンド標的指向性薬物結合体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210393786A1 (https=) |
| EP (1) | EP3826681A4 (https=) |
| JP (2) | JP2021531312A (https=) |
| CN (1) | CN112672762B (https=) |
| AU (1) | AU2019312144B2 (https=) |
| CA (1) | CA3107778A1 (https=) |
| WO (1) | WO2020023323A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023511956A (ja) * | 2020-01-24 | 2023-03-23 | レゲネロン ファーマシューティカルス，インコーポレーテッド | タンパク質－抗ウイルス化合物コンジュゲート |
| US20210402001A1 (en) * | 2020-06-30 | 2021-12-30 | David I. Cohen | Zinc Porters, and their Monoclonal Antibody Conjugates, for the Prevention and Treatment of COVID-19 (SARS-CoV-2), Other Infections, and Cancers |
| WO2022006365A2 (en) * | 2020-07-02 | 2022-01-06 | Purdue Research Foundation | Tetrahydro-3h-pyrazolo quinolone and tetrahydro-3h-pyrrolo[3,2-f]quinoline-containing compounds and uses thereof |
| EP4178626A4 (en) * | 2020-07-13 | 2024-08-14 | University of Southern California | Universal car-nk cell targeting various epitopes of hiv-1 gp160 |
| US20240285776A1 (en) * | 2021-05-14 | 2024-08-29 | Purdue Research Foundation | Small molecule-based bi-specific immune cell tethers and their use in the treatment of enveloped virus infection |
| CA3220081A1 (en) * | 2021-07-28 | 2023-02-02 | Thomas Nittoli | Protein-antiviral compound conjugates |
| CA3249257A1 (en) * | 2022-04-19 | 2023-10-26 | Purdue Research Foundation | DOUBLE AND TRIPLE HAPTEN CONJUGATES, COMPOSITIONS, MANUFACTURING PROCESSES AND ASSOCIATED PROCESSING METHODS |
| CN116375647A (zh) * | 2023-01-21 | 2023-07-04 | 兰州大学 | 一种基于Click反应的CAR-T细胞药物递送平台及其构建方法与应用 |
| WO2025085664A1 (en) * | 2023-10-17 | 2025-04-24 | Mary Lynn Niedrauer | Conjugates, com positions and methods for treating influenza |
| WO2025133395A1 (en) | 2023-12-22 | 2025-06-26 | Forx Therapeutics Ag | Bicyclic (hetero)arylene wrn inhibitory compounds |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6692724B1 (en) * | 1999-10-25 | 2004-02-17 | Board Of Regents, The University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| IL153218A0 (en) * | 2000-06-02 | 2003-07-06 | Univ Texas | Ethylenedicysteine (ec) -drug conjugates |
| WO2002044324A2 (en) * | 2000-10-06 | 2002-06-06 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| CN105363034A (zh) * | 2008-05-23 | 2016-03-02 | 香港大学 | 治疗流感的联合疗法 |
| CA2790577A1 (en) * | 2010-02-25 | 2011-09-01 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| AU2011250970B2 (en) * | 2010-05-10 | 2016-12-15 | Sinica, Academia | Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses |
| CA2803348A1 (en) * | 2010-06-25 | 2012-04-19 | Purdue Research Foundation | Pathogen detection |
| US10130714B2 (en) * | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| EP4282419A1 (en) * | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| US10975112B2 (en) * | 2015-06-16 | 2021-04-13 | Hangzhou Dac Biotech Co., Ltd. | Linkers for conjugation of cell-binding molecules |
| EP3439675A4 (en) * | 2016-04-08 | 2019-12-18 | Purdue Research Foundation | METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY |
-
2019
- 2019-07-20 US US17/263,451 patent/US20210393786A1/en not_active Abandoned
- 2019-07-20 CA CA3107778A patent/CA3107778A1/en active Pending
- 2019-07-20 AU AU2019312144A patent/AU2019312144B2/en active Active
- 2019-07-20 EP EP19841376.7A patent/EP3826681A4/en active Pending
- 2019-07-20 CN CN201980056374.6A patent/CN112672762B/zh active Active
- 2019-07-20 JP JP2021504238A patent/JP2021531312A/ja active Pending
- 2019-07-20 WO PCT/US2019/042715 patent/WO2020023323A1/en not_active Ceased
-
2023
- 2023-12-18 JP JP2023212681A patent/JP2024029005A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531312A5 (https=) | ||
| JP4868698B2 (ja) | マクロファージが仲介する疾患の治療および診断 | |
| JP2025024041A5 (https=) | ||
| JP2017507931A5 (https=) | ||
| JP2022525704A5 (https=) | ||
| JP2020002172A5 (https=) | ||
| JP2018505674A5 (https=) | ||
| HRP20171580T1 (hr) | Ljudska monoklonska protutijela koja su specifična za protein e denga virusa serotipa 1 i njihova upotreba | |
| WO2007134037A3 (en) | Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments | |
| AU2015258801B2 (en) | One-step labeling of antibodies to high specific activity with actinium-225 | |
| DE05075555T1 (de) | Immuntherapie von Autoimmunerkrankungen durch die Verwendung von B-Zell-spezifischen Antikörpern | |
| JPS62181280A (ja) | トリコテセン結合体を含む抗腫瘍剤 | |
| JP2013534528A (ja) | 脂質とコンジュゲートする抗体 | |
| Jagadeesh et al. | Antibody drug conjugates (ADCs): changing the treatment landscape of lymphoma | |
| JP2013501807A5 (https=) | ||
| KR20200006546A (ko) | 항-folr1 면역접합체 및 항-pd-1 항체 조합물 | |
| WO2022040429A3 (en) | Vaccine compositions and antibodies for lyme disease | |
| JP2006511620A5 (https=) | ||
| Sharkey et al. | Biological considerations for radioimmunotherapy | |
| Mifsud et al. | Reducing the impact of influenza‐associated secondary pneumococcal infections | |
| JP2021501800A5 (https=) | ||
| JP2015529656A5 (https=) | ||
| US9289519B2 (en) | Alpha emitting constructs and uses thereof | |
| JP2010529950A5 (https=) | ||
| JPS61197528A (ja) | 免疫毒素製剤 |